(Q33640660)

28 July 2017

Trifluorothymidine versus adenine arabinoside in the treatment of herpes simplex keratitis (English)

1 reference

28 July 2017

Van Bijsterveld OP

1

1 reference

PubMed ID

6766733

28 July 2017

Post H

series ordinal

2

1 reference

PubMed ID

6766733

28 July 2017

language of work or name

English

0 references

publication date

1 January 1980

1 reference

British Journal of Ophthalmology

28 July 2017

1 reference

28 July 2017

64

1 reference

28 July 2017

1

1 reference

28 July 2017

33-36

1 reference

Clinical evaluation of adenine arabinoside and trifluorothymidine in the treatment of corneal ulcers caused by herpes simplex virus

28 July 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1039344

Clinical Evaluation of Trifluorothymidine in the Treatment of Herpes Simplex Corneal Ulcers

21 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1039344

Prospects in treating viral disease of the eye

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6766733

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A double blind clinical study of adenine arabinoside therapy of viral keratoconjunctivitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6766733

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Use of 5-iodo-2'-deoxyuridine (IDU) in treatment of herpes simplex keratitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6766733

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BJO.64.1.33

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

PubMed ID

6766733